by Don McLean | Mar 25, 2020 | Blog
Pharmaceutical Industry News Roundup: March 2020 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from March: Coronavirus (COVID-19) Update: FDA continues to facilitate development of...
by Don McLean | Mar 4, 2020 | News
MMS Holdings to Debut Datacise Integrated Safety Explorer to Detect Safety Signals Using Real-World Evidence During PHUSE/FDA Data Science Innovation Challenge CANTON, Mich. (March 4, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today...
by Don McLean | Feb 7, 2020 | Blog
The New Roaring 20s: 12 Experts Provide Pharmaceutical Insights for the Decade Ahead by Aaron Robert The pharmaceutical industry—and healthcare in general—are in constant stages of innovation. According to the International Federation of Pharmaceutical Manufacturers...
by Don McLean | Nov 5, 2019 | Blog
Pharmaceutical Industry News Roundup: October 2019 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from last month: Researchers find 15% of trials could be replicated using real world...
by Don McLean | Oct 3, 2019 | Blog
Webinar: The Programmers Approach to Real World Data and Using Real World Evidence in Research and Healthcare by MMS Holdings and MichBio.org This webinar is intended to help guide individuals towards a better understanding of core concepts and requirements for using...
